The Clayton team recently visited Vaccinopolis, the impressive and ultra-modern research facility on the University of Antwerp campus. This pioneering site focuses on accelerating research into infectious diseases and vaccine evaluation, with particular attention to clinical trials and safety.
During an inspiring tour led by Bart Van Meerbergen, Head of Operations at Vaccinopolis, we gained unique insights into the operation and organisation of the centre. Vaccinopolis combines clinical research, specialised laboratories and multidisciplinary expertise in one integrated infrastructure – a facility recognised worldwide as a benchmark.
For this advanced facility, Clayton supplied an electric steam generator type V-15 (150 kWe).
This system features fully modulating, thyristor-controlled power regulation, providing a highly accurate, energy-efficient and dependable steam supply.
In a research environment where control and precision are critical, this is the perfect match. Clayton’s technology supports Vaccinopolis in maintaining the highest quality standards in their research processes.
At Clayton, we are especially proud that our steam solution contributes to the operation of this international reference centre in vaccine research.
We thank the Vaccinopolis team for their trust and look forward to continuing to support them with sustainable and innovative steam technology.
Vaccinopolis
Clayton is a global manufacturer of industrial steam solutions. European production and engineering have been carried out since 1961 in Bornem, Belgium, where Clayton of Belgium serves as the EMEA headquarters and main production hub for Europe, the Middle East, and Africa. The global headquarters of the Clayton Group is located in California, with additional production facilities in Mexico and Europe, and subsidiaries in France, Germany, the Netherlands, Spain, and the United Kingdom.
WORK SAFETY
